Major updates to FDA-recognized Clinical and Laboratory Standards Institute breakpoints are a win for the fight against antimicrobial resistance

Antimicrobial resistance is a global health crisis, and clinical laboratories play a crucial role in detecting it. However, changing interpretive standards and increased FDA regulation have challenged the ability of these laboratories to conduct antimicrobial susceptibility testing. The FDA’s pragmatic approach to AST is a significant win for laboratories and patients.